arrow
E

Eddie Lau

university of melbourne
H指数:25
被引数:2,649

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator

在1.5T磁共振成像-直线加速器上监测化疗放疗期间胶质母细胞瘤的动态变化

2026-05-280
OAAI
Clinical outcomes and quality of life in glioblastoma patients treated with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac in an Australian setting

澳大利亚环境下使用1.5 T MR-Linac进行MR引导自适应放疗的胶质母细胞瘤患者的临床结局和生活质量

2026-02-190
OA
MULTI-SITE, PROSPECTIVE TRIAL EVALUATING FET-PET IN GLIOBLASTOMA (FIG) STUDY (TROG 18.06): CENTRAL NUCLEAR MEDICINE AND RADIATION ONCOLOGY REVIEW OF FET-PET BIOLOGIC TARGET VOLUME DELINEATION FOR RADIATION PLANNING

多中心前瞻性试验评估胶质母细胞瘤中FET-PET的应用(FIG研究,TROG 18.06):中心核医学与放射肿瘤学对放射治疗计划中FET-PET生物靶区勾画的审查

2025-11-010
OAAI
MULTI-SITE, PROSPECTIVE TRIAL EVALUATING FET-PET IN GLIOBLASTOMA (FIG) STUDY (TROG 18.06): PRELIMINARY RESULTS OF CENTRAL NUCLEAR MEDICINE REVIEW OF FET-PET BIOLOGIC TARGET VOLUME DELINEATION FOR RADIATION PLANNING
2024-11-110
PRE
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06

胶质母细胞瘤中FET PET生物体积的描述和一致性: 来自评估胶质母细胞瘤中FET PET的前瞻性多中心试验 (FIG) 研究-TROG 18.06的核医学认证计划的结果

2023-08-119
OAAI
Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature

前列腺特异性膜抗原-正电子发射断层扫描/计算机断层扫描 (psma-pet/CT) 引导的立体定向消融放射治疗寡转移性前列腺癌: 单机构经验和已发表文献的回顾

2019-09-1147
OAAI